Corporate Governance

Corporate governance tailored for a dynamic biotech environment

The Board of Directors has adopted a set of corporate governance practices and a code of conduct appropriate for the size, complexity, and operations of the company and its subsidiaries. The ongoing relevance and effectiveness of this framework will be periodically reviewed to reflect changing circumstances. The Company’s corporate governance framework is reviewed and developed in light of ASX Corporate Governance Principles and Recommendations.

In addition to the key policies in our Board Charter above, our other key policies are:

Whistleblower Policy

Continuous Disclosure Policy

Diversity Policy

Anti-Bribery and Corruption Policy

Chief Operating Officer, General Counsel & Company Secretary

Deanne Miller
Immutep Limited
deanne.miller@immutep.com

Level 32, Suite 32.07 Australia Square
264 George Street, Sydney
NSW 2000, Australia

Auditor

PricewaterhouseCoopers

One International Towers Sydney
Watermans Quay Barangaroo, NSW 2000, Australia

Environmental, Social and Governance (ESG) Report

At Immutep we are committed to improving the lives of our patients, employees and communities. Whilst our product candidates and the industry we work within have the potential to make a real difference to people’s lives, we are mindful that the paths we take to develop our candidates and how we conduct our business are just as important. Hence, we are progressing our ESG initiatives and have implemented this ESG report to explain to our stakeholders how we are addressing and tracking on a range of Environmental, Social and Governance matters.

download

Corporate Governance

Corporate governance tailored for a dynamic biotech environment

Immutep’s Board Charter

Immutep’s Constitution

Corporate Governance Statement

Environmental, Social and Governance (ESG) Report